Member Info for neon

Because he had shorts open and was panicking as it started to move up lol

Lol what an idiot

It looks like you left your shorts open and now panicking! lol

Not just that, read this bit

https://twitter.com/LseNeon/status/1717196024907722988

Valuation: Fusion’s market capitalisation is £3.4m and the company currently has c.£1m in

cash, so its EV is in the region of £2.4m. While we acknowledge that the company has to

succeed in its turnaround to regain shareholder support, we consider that this figure does

not to ascribe any value to Fusion’s potentially valuable and class-leading technologies,

that could be worth a multiple of this figure.

Company Note

Finals

03 October 2023

Fusion Antibodies plc (FAB.L)

Fusion now has cash of around £1m, giving it a cash runway in excess of 15 months on its reduced cost base.

The answer is next to nothing. He just works at Bracco, doesn’t own it & used it to become polx Ned to earn more bucks for himself that’s all. Hugo Drayton the guy from future plc also joined gfinity, everybody thought future is gonna buy gfinity. Gfin dropped from over 5p to 0.07p with failure after failure but that bid never came.

Lol

I had to take a lot of abuse for raising my concerns first on 5 Oct 2023 14:50, then posting about that Aussie tech gaining market interests. Polx was meant to meet FDA this month so any news on that will help. Unfortunately the CEO never purchased any shares after the interim tells you all you need. Yes, I've reduced my exposure substantially but would love to increase it back provided they report material progress otherwise it will keep going down and down, something that it's been doing since the philips collaboration. I've asked the company several times in last few days but ended up with complete silence which just accelerates my fears. I understand the CEO doesn't care as he has nothing to lose, don't think he is not loyal to the shareholders. Hopefully that amati guy will pull some strings and get the funding issues sorted. I hope the company proves our criticism/doubts wrong and start providing something, otherwise..

GLA

Hmm, good find, didn't know they have collaborated before. I hope the company doesn't get sold in cheap, instead sign new a multi year contract for their new AI/ML service. I don't know if they have made further progress but if they can achieve what they said they will, the SP will rerate upwards sharply IMO.

you just made me laugh!

you are probably not familiar with bids and it’s full story hence making this weird bullish comments. it’s good to have years of experiences so use it to see how much cash they are left with and drapers call to take the company private years after enjoying a lavish lifestyle on shareholders expense. i sold out ages ago when things became clearer to me. since then posted here occasionally after news when i spotted anything good or bad. it’s fine if you want to trade but stop making unrealistic comments to lure investors into this bull**** company which is about to go under. helx and girdz are regular posters here, not me

Please just listen to Girdz and helx and stay miles away from this company. They are plenty of excellent companies with sound balance sheet on AIM, pick those over this awful company.

I invested here before, supported with Girdz and others, presented counter posts to helx, challenged him God knows how many times, then Girdz saw lights, sold out and kept warning us and I'm sorry to say both were spot on. Not always but mostly they were right as the company's reporting has gone from bad to the worst and now this.

It's a proper proper lifestyle company with an awful history and going nowhere but down. Save your hard earned cash for a better investment elsewhere. It might flash once or twice but eventually you will lose it. DO NOT fall for that trap.

GL

Finwittrader

https://www.linkedin.com/posts/fusion-antibodies-plc_congratulations-weknowantibodies-challengeus-activity-7119608750159601664-DMQL/?utm_source=share&utm_medium=member_desktop

The CEO commented saying, "It is an absolute pleasure to have Nicola step up to the Operations Manager roll in readiness for the influx of projects resulting from our new services. She is one of the most competent and talented Managers and Scientists I have had the pleasure to work with (it must be the Fusion training!). Onward and upward, Nicola!"

Let me repeat this bit, ".. for the influx of projects resulting from our new services." The order book has risen three folds as per the investor meet presentation so don't be fooled by lower volume as it can increase substantially with news as we have seen before. No advice but most probably this is the best time to accumulate when it's quiet. GL

I’m also bored fed up with your constant ramping! Share price has done nothing but to go down and down and down so stop responding, better just block me

just block me you ******* idiot

Polarean shareprice won’t go down because of my post, it won’t go up because of somebody else’s post. It will go up and down based on number of buyers and sellers. I got frustrated of waiting, ended up with this Aussie tech after trying to get information on lung imaging on google, started panicking and shared it with this board to see if it’s was known to anybody. people in the know were selling prior to the results probably for similar reasons. Is it a crime to raise and reply to abusive emails with facts?

Jacobjohn7, please stop being a bully and start posting abusive messages! John stated I lied about that Aussie tech getting FDA approval, I have proven him wrong. Why have you started calling me names?

ASX-listed Cyclopharm announced on Monday it had received Food and Drug Administration (FDA) approval for its Technegas product, a radiopharmaceutical that's been used to help diagnose or rule out pulmonary embolisms in 4.7 million patients in 64 countries since the 1980s.

Cyclopharm chief executive and managing director Dr James McBrayer told AAP that FDA approval would be transformational for the $265 million Sydney-based company.

https://thewest.com.au/business/us-regulators-approval-a-game-changer-for-cyclopharm-c-12081788

Wrong call

It's just cheaper and due to the higher cost environment, not sure how the hospitals will prioritise their budget. It's just that feeling really, whatif we haven't been told the truth

DYM...Turbo

Not sure what you mean by better! I thought it's the price patients would be charged per scan. Ultimately ofcourse the insurance companies will pay for it